Loading...

241 posters, 10 topics, 7 sessions, 899 authors, 296 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

The AAPS 103rd Annual Meeting 2025

May 24-27, 2025 | Austin, Texas

The AAPS 103rd Annual Meeting 2025 banner

P24

Evaluating Clinical, Aesthetic, And Patient-reported Outcomes: A Comparative Study Of Reduction Mammoplasty Versus Oncoplastic Breast Reconstruction

Part of Topic

Breast Reconstruction

Comparative Analysis of Reduction Mammaplasty vs. Oncoplastic Breast Reconstruction: Assessing Clinical, Aesthetic, and Patient-Reported Outcomes

Introduction: 

•Oncoplastic breast reconstruction benefits women undergoing breast conservation therapy (BCT) by alleviating macromastia symptoms and enhancing symmetry, shape, and cosmesis.
•Compared to BCT alone:
1.With Increased OR time
2.Additional surgical site
3.Location of tumor limits pedicle choice
•No prior investigation on (a) post-operative clinical outcomes, (b) patient reported quality-of-life, and (c) aesthetic results of oncoplastic reconstruction (OP) compared to standard bilateral breast reduction (BBR). 
 
Methods: 
•Single-surgeon, single-institution retrospective chart review from 4/2022-12/2023.
•Data collection on:

(a) Patient demographics and post-op clinical data per EMR review

(b) Patient-reported QoL outcomes: pre- vs. post-op BREAST-Q survey results

(c) Aesthetic outcomes: Ten 1:1 propensity score matched cases

Results: 

•92 total patients, 56 (60.9%) received BBR and 36 (39.1%) oncoplastic reconstruction.
•BBR cohort significantly younger and with >resection weight.
•OP cohort with higher BMI and ASA class.

Clinical Outcomes:

•OP and BBR cohorts with comparable post-op clinical complication profile.

QoL Outcomes:

•Both cohorts with significant improvements in all BREAST-Q pairings (psychosocial, sexual, physical well-being and breast satisfaction), through greater increase in BBR group
 
Aesthetic Outcomes: 
 
Conclusion: 
•Notable differences in demographics and patient characteristics (age, ASA, race)
•Both groups with significant QoL improvement
•Comparable clinical and aesthetic results between the two cohorts
•Oncoplastic breast reconstruction be more readily discussed as a favorable surgical option when lumpectomy is indicated
aaps2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.